Skip to main content

Advertisement

SpringerLink
Log in

Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Nevirapine (NVP) and efavirenz (EFV) are antiretroviral drugs belonging to potent class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) widely used for the treatment human immunodeficiency virus (HIV) infection. It has been demonstrated that NVP and EFV are able to cross the blood–brain barrier and arrive at the central nervous system (CNS), causing important adverse effects related to their presence within this tissue. Considering that the exact mechanisms responsible for CNS toxicity associated with NVP and EFV remain unknown and that creatine kinase (CK) plays an important role in cell energy homeostasis, in the present work we evaluated CK activity in brain of mice after chronic administration of these drugs. Our results demonstrated that NVP and EFV significantly inhibited CK activity in cerebellum, hippocampus, striatum and cortex of mice. Although it is difficult to extrapolate our findings to the human condition, the inhibition of brain CK activity by NVP and EFV may be associated with neurological adverse symptoms of these drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Adkins JC, Noble S (1998) Efavirenz. Drugs 56:1055–1064

    Article  PubMed  CAS  Google Scholar 

  • Aksenov M, Butterfield DA, Markesbery WR (2000) Oxidative modification of creatine kinase BB in Alzheimer’s disease brain. J Neurochem 74:2520–2527

    Article  PubMed  CAS  Google Scholar 

  • Anthonypillai C, Sanderson RN, Gibbs JE, Thomas SA (2004) The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig. J Pharmacol Exp Ther 308:912–920

    Article  PubMed  CAS  Google Scholar 

  • Anthonypillai C, Gibbs JE, Thomas SA (2006) The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses. Cerebrospinal Fluid Res 3:1–10

    Article  PubMed  Google Scholar 

  • Arendt G, de Nocker D, von Giesen HJ, Nolting T (2007) Neuropsychiatric side effects of efavirenz therapy. Expert Opin Drug Saf 6:147–154

    Article  PubMed  CAS  Google Scholar 

  • Assis LC, Scaini G, Di-Pietro PB, Castro AA, Comim CM, Streck EL, Quevedo J (2007) Effect of antipsychotics on creatine kinase activity in rat brain. Basic Clin Pharmacol Toxicol 101:315–319

    Article  PubMed  CAS  Google Scholar 

  • Bessman SP, Carpenter CL (1985) The creatine–creatine phosphate energy shuttle. Annu Rev Biochem 54:831–865

    Article  PubMed  CAS  Google Scholar 

  • Bickel M, Stephan C, Rottmann C, Carlebach A, Haberl A, Kurowski M, Staszewski S (2005) Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis. Scand J Infect Dis 37:520–522

    Article  PubMed  Google Scholar 

  • Blass JP (2001) Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J Neurosci Res 66:851–856

    Article  PubMed  CAS  Google Scholar 

  • Búrigo M, Roza CA, Bassani C, Feier G, Dal-Pizzol F, Quevedo J, Streck EL (2006) Decreased creatine kinase activity caused by electroconvulsive shock. Neurochem Res 31:877–881

    Article  PubMed  Google Scholar 

  • David S, Shoemaker M, Haley BE (1998) Abnormal properties of creatine kinase in Alzheimer’s disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol–membrane partitioning. Mol Brain Res 54:276–287

    Article  PubMed  CAS  Google Scholar 

  • Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:1249–1253

    Article  PubMed  CAS  Google Scholar 

  • Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK (2002) Panel on clinical practices for the treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the panel on clinical practices for treatment of HIV. MMWR Recomm Rep 51:1–55

    PubMed  Google Scholar 

  • Fumaz CR, Munõz-Moreno JA, Moltó J, Negredo E, Ferrer MJ, Sirera G, Pérez-Alvarez N, Gómez G, Burger D, Clotet B (2005) Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence. J Acquir Immune Defic Syndr 38:560–565

    Article  PubMed  Google Scholar 

  • Gibbs JE, Gaffen Z, Thomas SA (2006) Nevirapine uptake into the central nervous system of the Guinea pig: an in situ brain perfusion study. J Pharmacol Exp Ther 317:746–751

    Article  PubMed  CAS  Google Scholar 

  • Gross WL, Bak MI, Ingwall JS, Arstall MA, Smith TW, Balligand JL, Kelly RA (1996) Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci USA 93:5604–5609

    Article  PubMed  CAS  Google Scholar 

  • Gutiérrez F, Navarro A, Padilla S, Antón R, Masiá M, Borrás J, Martín-Hidalgo A (2005) Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring. Clin Infect Dis 41:1648–1653

    Article  PubMed  Google Scholar 

  • Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM Clifford DB, Hulgan T, Marzolini C, Acosta EP (2004) Pharmacogenetics of efavirenz and central nervous system side effects: an adult AIDS clinical trials group study. AIDS 18(18):2391–2400

    PubMed  CAS  Google Scholar 

  • Hawkins T, Geist C, Young B, Giblin A, Mercier RC, Thornton K, Haubrich R (2005) Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients. HIV Clin Trials 6:187–196

    Article  PubMed  Google Scholar 

  • Heales SJ, Bolaños JP, Stewart VC, Brookes PS, Land JM, Clark JB (1999) Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410:215–228

    Article  PubMed  CAS  Google Scholar 

  • Hughes BP (1962) A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin Chim Acta 7:597–604

    Article  PubMed  CAS  Google Scholar 

  • Jost CR, Van der Zee CE, Zandt HJ, Oerlemans F, Verheij M, Streijger F, Fransen J, Heerschap A, Cools AR, Wieringa B (2002) Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci 15:1692–1706

    Article  PubMed  Google Scholar 

  • Khuchua ZA, Qin W, Boero J, Cheng J, Payne RM, Saks VA, Strauss AW (1998) Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues. J Biol Chem 273:22990–22996

    Article  PubMed  CAS  Google Scholar 

  • Lewis W, Kohler JJ, Hosseini SH, Haase CP, Copeland WC, Bienstock RJ Ludaway T, McNaught J, Russ R, Stuart T, Santoianni R (2006) Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS 20:675–684

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267

    PubMed  CAS  Google Scholar 

  • Maggiolo F (2007) Efavirenz. Expert Opin Pharmacoter 8(8):1137–1145

    Article  CAS  Google Scholar 

  • Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, Buclin T (2001) Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 15:71–75

    Article  PubMed  CAS  Google Scholar 

  • Piacenti FJ (2006) An update and review of antiretroviral therapy. Pharmacotherapy 26:1111–1133

    Article  PubMed  CAS  Google Scholar 

  • Rihs TA, Begley K, Smith DE, Sarangapany J, Callaghan A, Kelly M, Post JJ, Gold J (2006) Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med 7:544–548

    Article  PubMed  CAS  Google Scholar 

  • Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology 56:257–260

    PubMed  CAS  Google Scholar 

  • Schlattner U, Wallimann T (2000) Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. J Biol Chem 275:17314–17320

    Article  PubMed  CAS  Google Scholar 

  • Schurr A (2002) Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem Int 41:1–8

    Article  PubMed  CAS  Google Scholar 

  • Streck EL, Amboni G, Scaini G, Di-Pietro PB, Rezin GT, Valvassori SS, Luz G, Kapczinski F, Quevedo J (2008) Brain creatine kinase activity in an animal model of mania. Life Sci 82:424–429

    Article  PubMed  CAS  Google Scholar 

  • Streijger F, Jost CR, Oerlemans F, Ellenbroek BA, Cools AR, Wieringa B, Van der Zee CE (2004) Mice lacking the UbCKmit isoform of creatine kinase reveal slower spatial learning acquisition, diminished exploration and habituation, and reduced acoustic startle reflex responses. Mol Cell Biochem 256/257:305–318

    Article  CAS  Google Scholar 

  • Streijger F, Oerlemans F, Ellenbroek BA, Jost CR, Wieringa B, Van der Zee CE (2005) Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav Brain Res 157:219–234

    Article  PubMed  CAS  Google Scholar 

  • Tashima KT, Caliendo AM, Ahmad M, Gormley JM, Fiske WD, Brennan JM, Flanigan TP (1999) Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy. J Infect Dis 180:862–864

    Article  PubMed  CAS  Google Scholar 

  • Tomimoto H, Yamamoto K, Homburger HA, Yanagihara T (1993) Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathol 86:447–455

    PubMed  CAS  Google Scholar 

  • Treisman GJ, Kaplin AI (2002) Neurologic and psychiatric complications of antiretroviral agents. AIDS 16:1201–1215

    Article  PubMed  CAS  Google Scholar 

  • van Praag RM, van Weert EC, van Heeswijk RP, Zhou XJ, Sommadossi JP, Jurriaans S, Lange JM, Hoetelmans RM, Prins JM (2002) Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy. Antimicrob Agents Chemother 46:896–899

    Article  PubMed  Google Scholar 

  • von Giesen HJ, Köller H, Theisen A, Arendt G (2002) Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients. J Acquir Immune Defic Syndr 29:363–367

    Google Scholar 

  • Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 281:21–40

    PubMed  CAS  Google Scholar 

  • Wise ME, Mistry K, Reid S (2002) Drug points: neuropsychiatric complications of nevirapine treatment. BMJ 324:879

    Article  PubMed  Google Scholar 

  • Wynn HE, Brundage RC, Fletcher CV (2002) Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs 16:595–609

    Article  PubMed  CAS  Google Scholar 

  • Zanette F, Victor EG, Scaini G, Di-Pietro PB, Cardoso DC, Cristiano MP, Dal-Pizzol F, Paula MM, Streck EL (2007) Modulation of creatine kinase activity by ruthenium complexes. J Inorg Biochem 101:267–273

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Apoio à Pesquisa Científica e Tecnológica do Estado de Santa Catarina (FAPESC) and Universidade do Extremo Sul Catarinense (UNESC).

Author information

Authors and Affiliations

  1. Laboratório de Fisiopatologia Experimental, Unidade Acadêmica de Ciências da Saúde, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil

    Emilio L. Streck, Giselli Scaini & Gislaine T. Rezin

  2. Laboratório de Imunologia e Mutagênese, Unidade Acadêmica de Ciências da Saúde, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil

    Jeverson Moreira, Celine M. Fochesato & Pedro R. T. Romão

Authors
  1. Emilio L. Streck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giselli Scaini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gislaine T. Rezin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeverson Moreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Celine M. Fochesato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pedro R. T. Romão
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro R. T. Romão.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Streck, E.L., Scaini, G., Rezin, G.T. et al. Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity. Metab Brain Dis 23, 485–492 (2008). https://doi.org/10.1007/s11011-008-9109-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-008-9109-2

Keywords

Search

Navigation